Literature DB >> 10744229

Biomolecular mechanisms of calvarial bone induction: immature versus mature dura mater.

J A Greenwald1, B J Mehrara, J A Spector, G S Chin, D S Steinbrech, P B Saadeh, J S Luchs, M F Paccione, G K Gittes, M T Longaker.   

Abstract

The ability of newborns and immature animals to reossify calvarial defects has been well described. This capacity is generally lost in children greater than 2 years of age and in mature animals. The dura mater has been implicated as a regulator of calvarial reossification. To date, however, few studies have attempted to identify biomolecular differences in the dura mater that enable immature, but not mature, dura to induce osteogenesis. The purpose of these studies was to analyze metabolic characteristics, protein/gene expression, and capacity to form mineralized bone nodules of cells derived from immature and mature dura mater. Transforming growth factor beta-1, basic fibroblast growth factor, collagen type IalphaI, osteocalcin, and alkaline phosphatase are critical growth factors and extracellular matrix proteins essential for successful osteogenesis. In this study, we have characterized the proliferation rates of immature (6-day-old rats, n = 40) and mature (adult rats, n = 10) dura cell cultures. In addition, we analyzed the expression of transforming growth factor beta-1, basic fibroblast growth factor-2, proliferating cell nuclear antigen, and alkaline phosphatase. Our in vitro findings were corroborated with Northern blot analysis of mRNA expression in total cellular RNA isolated from snap-frozen age-matched dural tissues (6-day-old rats, n = 60; adult rats, n = 10). Finally, the capacity of cultured dural cells to form mineralized bone nodules was assessed. We demonstrated that immature dural cells proliferate significantly faster and produce significantly more proliferating cell nuclear antigen than mature dural cells (p < 0.01). Additionally, immature dural cells produce significantly greater amounts of transforming growth factor beta-1, basic fibroblast growth factor-2, and alkaline phosphatase (p < 0.01). Furthermore, Northern blot analysis of RNA isolated from immature and mature dural tissues demonstrated a greater than 9-fold, 8-fold, and 21-fold increase in transforming growth factor beta-1, osteocalcin, and collagen IalphaI gene expression, respectively, in immature as compared with mature dura mater. Finally, in keeping with their in vivo phenotype, immature dural cells formed large calcified bone nodules in vitro, whereas mature dural cells failed to form bone nodules even with extended culture. These studies suggest that differential expression of growth factors and extracellular matrix molecules may be a critical difference between the osteoinductive capacity of immature and mature dura mater. Finally, we believe that the biomolecular bone- and matrix-inducing phenotype of immature dura mater regulates the ability of young children and immature animals to heal calvarial defects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744229     DOI: 10.1097/00006534-200004040-00018

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  24 in total

1.  Tissue interactions between craniosynostotic dura mater and bone.

Authors:  Gregory M Cooper; Emily L Durham; James J Cray; Michael I Siegel; Joseph E Losee; Mark P Mooney
Journal:  J Craniofac Surg       Date:  2012-05       Impact factor: 1.046

2.  Operative management of growing skull fractures: a technical note.

Authors:  Ashutosh Singhal; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2007-12-21       Impact factor: 1.475

3.  Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects.

Authors:  Benjamin Levi; Emily R Nelson; Shuli Li; Aaron W James; Jeong S Hyun; Daniel T Montoro; Min Lee; Jason P Glotzbach; George W Commons; Michael T Longaker
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

4.  Dipyridamole enhances osteogenesis of three-dimensionally printed bioactive ceramic scaffolds in calvarial defects.

Authors:  Jonathan M Bekisz; Roberto L Flores; Lukasz Witek; Christopher D Lopez; Christopher M Runyan; Andrea Torroni; Bruce N Cronstein; Paulo G Coelho
Journal:  J Craniomaxillofac Surg       Date:  2017-11-21       Impact factor: 2.078

5.  Histologic and histomorphometric evaluation of bone regeneration using nanocrystalline hydroxyapatite and human freeze-dried bone graft : An experimental study in rabbit.

Authors:  Rokhsareh Sadeghi; Mohammad Najafi; Hassan Semyari; Fatemeh Mashhadiabbas
Journal:  J Orofac Orthop       Date:  2017-01-27       Impact factor: 1.938

6.  Heterotopic Ossification of the Calvarium Following Bilateral Craniectomies in Traumatic Brain Injury.

Authors:  Rafael A Vega; Leslie Hutchins
Journal:  Ochsner J       Date:  2017

7.  Single-Cell Transcriptomic Analyses of the Developing Meninges Reveal Meningeal Fibroblast Diversity and Function.

Authors:  John DeSisto; Rebecca O'Rourke; Hannah E Jones; Bradley Pawlikowski; Alexandra D Malek; Stephanie Bonney; Fabien Guimiot; Kenneth L Jones; Julie A Siegenthaler
Journal:  Dev Cell       Date:  2020-07-06       Impact factor: 12.270

Review 8.  Hand in glove: brain and skull in development and dysmorphogenesis.

Authors:  Joan T Richtsmeier; Kevin Flaherty
Journal:  Acta Neuropathol       Date:  2013-03-23       Impact factor: 17.088

9.  An exploratory study on the efficacy of rat dedifferentiated fat cells (rDFATs) with a poly lactic-co-glycolic acid/hydroxylapatite (PLGA/HA) composite for bone formation in a rat calvarial defect model.

Authors:  Yoshinori Shirakata; Toshiaki Nakamura; Yukiya Shinohara; Katsuyoshi Taniyama; Kenji Sakoda; Takehiko Yoshimoto; Kazuyuki Noguchi
Journal:  J Mater Sci Mater Med       Date:  2013-12-21       Impact factor: 3.896

10.  Impaired meningeal development in association with apical expansion of calvarial bone osteogenesis in the Foxc1 mutant.

Authors:  Philaiporn Vivatbutsiri; Shizuko Ichinose; Marjo Hytönen; Kirsi Sainio; Kazuhiro Eto; Sachiko Iseki
Journal:  J Anat       Date:  2008-04-14       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.